Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 572171, 9 pages
Research Article

TLR3 Plays Significant Roles against HBV-Associated HCC

1Department of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China
2Department of Pathological Anatomy, Nantong University, Nantong, Jiangsu 226001, China

Received 28 July 2014; Revised 13 November 2014; Accepted 13 November 2014

Academic Editor: Zhongxia Wang

Copyright © 2015 Xiao-lan Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Kangkana Kataki, Parikhit Borthakur, Namrata Kumari, Manab Deka, Amal Ch Kataki, and Subhash Medhi, “Association of mRNA expression of toll-like receptor 2 and 3 with hepatitis B viral load in chronic hepatitis, cirrhosis, and hepatocellular carcinoma,” Journal of Medical Virology, vol. 89, no. 6, pp. 1008–1014, 2017. View at Publisher · View at Google Scholar
  • Marc Bonnin, Nadim Fares, Barbara Testoni, Yann Estornes, Kathrin Weber, Béatrice Vanbervliet, Lydie Lefrançois, Amandine Garcia, Alain Kfoury, Floriane Pez, Isabelle Coste, Pierre Saintigny, Alain Viari, Kévin Lang, Baptiste Guey, Valérie Hervieu, Brigitte Bancel, Birke Bartoch, David Durantel, Toufic Renno, Philippe Merle, and Serge Lebecque, “KfouryToll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis,” Journal of Hepatology, 2019. View at Publisher · View at Google Scholar
  • Bing Gao, Shicheng Li, Zhen Tan, Leina Ma, and Liu, “ACTG1 and TLR3 are biomarkers for alcohol-associated hepatocellular carcinoma,” Oncology Letters, vol. 17, no. 2, pp. 1714–1722, 2019. View at Publisher · View at Google Scholar